Quarterly report pursuant to Section 13 or 15(d)

CONDENDSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS EQUITY (DEFICIT) (Unaudited)

v3.23.1
CONDENDSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS EQUITY (DEFICIT) (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
Total
Subordinate Voting Shares
Super Voting Shares
Share Capital
Accumulated Deficit
Balance, shares at Dec. 31, 2021   111,806 203    
Balance, amount at Dec. 31, 2021 $ 70,307     $ 189,368 $ (119,061)
Net income (4,057)     0 (4,057)
Share-based compensation expense, shares   220      
Share-based compensation expense, amount 161     161 0
Share-based compensation expense 161        
Balance, shares at Mar. 31, 2022   112,026 203    
Balance, amount at Mar. 31, 2022 66,411     189,529 (123,118)
Balance, shares at Dec. 31, 2022   121,770 203    
Balance, amount at Dec. 31, 2022 48,117     191,742 (143,625)
Net income (4,040)     0 (4,040)
Share-based compensation expense 60     60 0
Balance, shares at Mar. 31, 2023   121,770 203    
Balance, amount at Mar. 31, 2023 $ 44,137     $ 191,802 $ (147,665)